Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification
Journal of Affective Disorders · 2024
DOI: 10.1016/j.jad.2024.08.182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Yiming Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Chinese Medicine, Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Trea…. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Stroke, Genome-Wide Association Study, Transcriptome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Health Commission of Henan Province, Scientific Research Foundation of Hunan Provincial Education Department, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
OBJECTIVE: Stroke is a highly prevalent and disabling disease whose disease mechanisms are not fully understood. The discovery of disease-associated proteins with genetic evidence of pathogenicity provides an opportunity to identify new therapeutic targets. METHOD: We examined the observed and causal associations of thousands of plasma and inflammatory proteins that were measured using affinity-based proteomic assays. First, we pooled >3000 relevant proteins using a fixed-effects meta-analysis of 2 population-based studies involving 48,383 participants, then investigated the causal effects of stroke and its subtype-associated proteins by forward Mendelian randomization using cis-protein quantitative locus genetic tools identified from genome-wide association studies of these >48,000 individuals. To improve the accuracy of causal estimation, we implemented a systematic Mendelian randomization model that accounts for cascading imbalances between instruments and tested the robustness of causal estimation through multi-method analyses. To further validate the hypothesis that ginsenoside Rg1 monomer acts on the five protein targets screened for drug-targeted regulation, we conducted a comparative analysis of the mRNA (gene) expression levels of a limited number of genes in the brain tissues of different groups of SD rats. The druggability of the candidate proteins was investigated and the mechanism of action and potential targeting side effects were explored by Phenome-wide MR. RESULTS: Six circulating proteins were identified to have a significant genetic association with stroke (PFDR 0.05, indicating less toxicity. CONCLUSIONS: The present study provides genetic evidence to support the potential efficacy of targeting the three druggable protein targets for the treatment of stroke. This is achieved by triangulating population genomic and proteomic data. Furthermore, the study validates the pathway mechanisms by which APRT, IL15RA, and VSIR dock ginsenoside Rg1 in animal models. This will help to prioritize stroke drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunan University of Chinese Medicine, Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, Changsha, China.
- Hunan University of Chinese Medicine, Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, Changsha, China. Electronic address…
Förderung
- Health Commission of Henan Province
- Scientific Research Foundation of Hunan Provincial Education Department
- National Natural Science Foundation of China
Zitieren
APA
Shi, Y., Bao, L., Li, Y., Ou, D., Li, J., Liu, X., Deng, N., Deng, C., Huang, X., Zhang, W., & Ding, H. (2024). Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.08.182
Vancouver
Shi Y, Bao L, Li Y, Ou D, Li J, Liu X, et al. Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.08.182
BibTeX
@article{Shi2024,
author = {Shi, Yiming and Bao, Le and Li, Yanling and Ou, Dian and Li, Jiating and Liu, Xiaodan and Deng, Nujiao and Deng, Changqing and Huang, Xiaoping and Zhang, Wei and Ding, Huang},
title = {Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification},
journal = {Journal of Affective Disorders},
year = {2024},
doi = {10.1016/j.jad.2024.08.182}
}
EUVIMED